Shareholder plans Rule 144 sale of 3,485 STIM shares (NASDAQ: STIM)
Rhea-AI Filing Summary
A holder of STIM common stock filed a notice of proposed sale under Rule 144 covering 3,485 shares, with an aggregate market value of $5,391.99, to be sold through Fidelity Brokerage Services LLC on or about 02/10/2026 on the NASDAQ.
The securities were acquired as restricted stock vesting from the issuer on 02/05/2026 as compensation. Shares of the issuer outstanding were 68,485,922 at the time referenced, providing context for the planned sale size.
Positive
- None.
Negative
- None.
FAQ
What does the STIM Form 144 filing disclose?
The filing discloses a planned Rule 144 sale of 3,485 STIM common shares. These shares, valued at about $5,391.99, are to be sold through Fidelity Brokerage Services LLC on or around 02/10/2026 on the NASDAQ exchange.
How many STIM shares are planned to be sold under this Form 144?
The notice covers a proposed sale of 3,485 STIM common shares. The filing lists an aggregate market value of $5,391.99 for these shares, with transactions expected to occur on or about 02/10/2026 via NASDAQ.
How were the STIM shares in this Form 144 acquired?
The 3,485 STIM shares were acquired on 02/05/2026 through restricted stock vesting. The filing describes the nature of the transaction as compensation from the issuer, with the same date listed for both acquisition and payment.
Which broker will handle the STIM Rule 144 share sale?
The proposed Rule 144 sale will be handled by Fidelity Brokerage Services LLC. The broker’s address is listed as 900 Salem Street, Smithfield, RI 02917, and the shares are expected to be sold on the NASDAQ exchange.
How many STIM shares are outstanding in this Form 144 context?
The filing reports 68,485,922 STIM common shares outstanding for the class referenced. This figure provides context for the planned sale of 3,485 shares under Rule 144 through Fidelity on or about 02/10/2026.
What representation does the seller make in the STIM Form 144?
The person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, as required by the Form 144 certification.